Soleus-Capital-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
75
Total Value
1388931935
Accession Number
0001802630-25-000006
Form Type
13F-HR
Manager Name
Soleus-Capital-Management-Lp
Data Enrichment
93% identified
70 identified5 unidentified

Holdings

75 positions • $1.4B total value
Manager:
Search and click to pin securities to the top
Page 4 of 4
829401108
Shares:240.0K
Value:$2.5M
% of Portfolio:0.2% ($2.5M/$1.4B)
Axsome Therapeutics, Inc.
Shares:17.0K
Value:$2.0M
% of Portfolio:0.1% ($2.0M/$1.4B)
ANAPTYSBIO, INC
Shares:102.1K
Value:$1.9M
% of Portfolio:0.1% ($1.9M/$1.4B)
Denali Therapeutics Inc.
Shares:135.0K
Value:$1.8M
% of Portfolio:0.1% ($1.8M/$1.4B)
Edgewise Therapeutics, Inc.
Shares:72.3K
Value:$1.6M
% of Portfolio:0.1% ($1.6M/$1.4B)
Y-mAbs Therapeutics, Inc.
Shares:350.0K
Value:$1.6M
% of Portfolio:0.1% ($1.6M/$1.4B)
Mereo BioPharma Group plc
Shares:687.0K
Value:$1.5M
% of Portfolio:0.1% ($1.5M/$1.4B)
CalciMedica, Inc.
Shares:783.9K
Value:$1.5M
% of Portfolio:0.1% ($1.5M/$1.4B)
Tectonic Therapeutic, Inc.
Shares:76.8K
Value:$1.4M
% of Portfolio:0.1% ($1.4M/$1.4B)
Adverum Biotechnologies, Inc.
Shares:287.2K
Value:$1.3M
% of Portfolio:0.1% ($1.3M/$1.4B)
ORTHOPEDIATRICS CORP
Shares:45.0K
Value:$1.1M
% of Portfolio:0.1% ($1.1M/$1.4B)
Abivax S.A.
Shares:125.0K
Value:$781.3K
% of Portfolio:0.1% ($781.3K/$1.4B)
Apogee Therapeutics, Inc.
Shares:16.0K
Value:$597.8K
% of Portfolio:0.0% ($597.8K/$1.4B)
IO Biotech, Inc.
Shares:192.7K
Value:$210.0K
% of Portfolio:0.0% ($210.0K/$1.4B)
Adaptive Biotechnologies Corp
Shares:10.0K
Value:$74.3K
% of Portfolio:0.0% ($74.3K/$1.4B)